Antimalarial resistance risk in Mozambique detected by a novel quadruplex droplet digital PCR assay
Antimicrobial Agents and Chemotherapy · 2024
DOI: 10.1128/aac.00346-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Noah Brown und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Virginia, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Antimalarials, Plasmodium falciparum, Drug Resistance, DNA Copy Number Variations. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundacao Millennium BCP, NIAID NIH HHS, Center for Global Health Equity (UVA).
Abstract (Originalsprache)
While the Plasmodium falciparum malaria parasite continues to cause severe disease globally, Mozambique is disproportionally represented in malaria case totals. Acquisition of copy number variations (CNVs) in the parasite genome contributes to antimalarial drug resistance through overexpression of drug targets. Of interest, piperaquine resistance is associated with plasmepsin 2 and 3 CNVs ( pfpmp2 and pfpmp3, respectively), while CNVs in the multidrug efflux pump, multidrug resistance-1 ( pfmdr1 ), increase resistance to amodiaquine and lumefantrine. These antimalarials are partner drugs in artemisinin combination therapies (ACTs) and therefore, CNV detection with accurate and efficient tools is necessary to track ACT resistance risk. Here, we evaluated ~300 clinically derived samples collected from three sites in Mozambique for resistance-associated CNVs. We developed a novel, medium-throughput, quadruplex droplet digital PCR (ddPCR) assay to simultaneously quantify the copy number of pfpmp3, pfpmp2 , and pfmdr1 loci in these clinical samples. By using DNA from laboratory parasite lines, we show that this nanodroplet-based method is capable of detecting picogram levels of parasite DNA, which facilitates its application for low yield and human host-contaminated clinical surveillance samples. Following ddPCR and the application of quality control standards, we detected CNVs in 13 of 229 high-quality samples (prevalence of 5.7%). Overall, our study revealed a low number of resistance CNVs present in the parasite population across all three collection sites, including various combinations of pfmdr1 , pfpmp2 , and pfpmp3 CNVs. The potential for future ACT resistance across Mozambique emphasizes the need for continued molecular surveillance across the region.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, University of Virginia, Charlottesville, Virginia, USA.
- Global Health and Tropical Medicine, GHTM, Associate Laboratory in Translation and Innovation Towards Global Health, LA-REAL, Instituto de Higiene e Medicina Tropical, IHMT, Universidade NOVA de Lisboa, UNL, Lisbon, Por…
- Instituto Nacional de Saúde, Maputo (INS), Maputo, Mozambique.
- Hospital Provincial de Matola, Matola, Mozambique.
- Division of Infectious Disease and International Health, University of Virginia, Charlottesville, Virginia, USA.
ORCID-Profile: Clemente da Silva, Fatima Nogueira, Jennifer L Guler
Förderung
- Fundacao Millennium BCP
- NIAID NIH HHS
- Center for Global Health Equity (UVA)
- Paroquia de Sao Nicolau-Lisboa
- Fundacao para a Ciencia e a Tecnologia
- Global Infectious Disease Institute (UVA)
- Instituto Camoes Bolsas Camoes
- HHS | National Institutes of Health (NIH)
Zitieren
APA
Brown, N., da Silva, C., Webb, C., Matias, D., Dias, B., Cancio, B., Silva, M., Viegas, R., Salvador, C., Chivale, N., Luis, S., Arnaldo, P., Zulawinska, J., Moore, C. C., Nogueira, F., & Guler, J. L. (2024). Antimalarial resistance risk in Mozambique detected by a novel quadruplex droplet digital PCR assay. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00346-24
Vancouver
Brown N, da Silva C, Webb C, Matias D, Dias B, Cancio B, et al. Antimalarial resistance risk in Mozambique detected by a novel quadruplex droplet digital PCR assay. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00346-24
BibTeX
@article{Brown2024,
author = {Brown, Noah and da Silva, Clemente and Webb, Caroline and Matias, Daniela and Dias, Brigite and Cancio, Beatriz and Silva, Miguel and Viegas, Ruben and Salvador, Crizolgo and Chivale, Nordino and Luis, Sonia and Arnaldo, Paulo and Zulawinska, Julia and Moore, Christopher C and Nogueira, Fatima and Guler, Jennifer L},
title = {Antimalarial resistance risk in Mozambique detected by a novel quadruplex droplet digital PCR assay},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
doi = {10.1128/aac.00346-24}
}
EUVIMED